Pharmaceutical Discount Agreements From February 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure

AOK NordWest Germany has Released a tender for Pharmaceutical Discount Agreements From February 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure in Pharmaceuticals. The tender was released on Dec 12, 2024.

Country - Germany

Summary - Pharmaceutical Discount Agreements From February 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure

Deadline - Dec 02, 2026

MT reference number - 99632747

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 99632747

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The subject of this publication is the conclusion of contracts pursuant to Section 130a Paragraph 8 of the Social Code Book V for several active ingredients within the framework of a so-called open house procedure: Under the specificatio n of uniform contract conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or groups of pharmaceutical companies are offered the conclusion of discount contracts pursuant to Section 130a Paragraph 8 of the Social Code Book V for the following active ingredients: Dimethyl fumarate (L04AX07) Ustekinumab (L04AC05) Adalimumab (L04AB04) Inclisiran (C10AX16) Iron (III) sodium gluconate complex (B03AC07) Emtric

Mt Ref Id - 99632747

Deadline - Dec 02, 2026

Share

Similar Tenders :